TRIMETHOPRIM

TRIMETHOPRIM was reported 85163 times

TRIMETHOPRIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CELLULITIS ENTEROCOCCAL 16 0.6667
1 PRE-ENGRAFTMENT IMMUNE REACTION 41 0.5125
2 SYNOVIAL FLUID ANALYSIS 44 0.5057
3 RADIATION INFLAMMATION 17 0.2125
4 VAGINAL FLATULENCE 63 0.2079
5 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 13 0.1940
6 T-CELL LYMPHOMA RECURRENT 11 0.1803
7 MICROVILLOUS INCLUSION DISEASE 12 0.1600
8 TOTAL LUNG CAPACITY ABNORMAL 41 0.1054
9 PROBIOTIC THERAPY 10 0.1010
10 CRYPTITIS 13 0.0935
11 SOFT TISSUE DISORDER 103 0.0929
12 TENOSYNOVITIS STENOSANS 49 0.0880
13 PULMONARY VASCULITIS 41 0.0762
14 CAPILLARITIS 19 0.0688
15 SYNOVIAL DISORDER 28 0.0615
16 FEAR OF EATING 19 0.0613
17 ANAL INFLAMMATION 36 0.0563
18 SWOLLEN JOINT COUNT 14 0.0560
19 RED BLOOD CELL SEDIMENTATION RATE DECREASED 14 0.0536
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 107 0.0534
21 GENITAL ULCERATION 41 0.0532
22 GRIP STRENGTH 12 0.0524
23 RESPIRATORY TRACT INFECTION BACTERIAL 25 0.0502
24 SARS-COV-2 TEST NEGATIVE 32 0.0474
25 SOFT TISSUE SWELLING 24 0.0423
26 APOPTOSIS 13 0.0421
27 ENCEPHALITIS VIRAL 51 0.0419
28 FEMALE GENITAL TRACT FISTULA 71 0.0415
29 SPIROMETRY ABNORMAL 24 0.0401
30 FACET JOINT SYNDROME 129 0.0396
31 ALLERGY TO CHEMICALS 47 0.0377
32 MITE ALLERGY 24 0.0366
33 C-REACTIVE PROTEIN 33 0.0356
34 LUPUS VULGARIS 44 0.0349
35 ABDOMINAL WALL HAEMORRHAGE 9 0.0345
36 SPLENIC ABSCESS 14 0.0344
37 SWOLLEN JOINT COUNT INCREASED 106 0.0332
38 BILIARY SEPSIS 15 0.0324
39 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 23 0.0314
40 SCLERITIS 49 0.0306
41 PNEUMONIA VIRAL 93 0.0291
42 GENITAL PAIN 43 0.0291
43 HEPATIC ENZYME DECREASED 13 0.0290
44 DEAFNESS TRANSITORY 24 0.0281
45 MYCOTIC ALLERGY 24 0.0281
46 URETERIC OBSTRUCTION 38 0.0278
47 NEURITIS 42 0.0272
48 MENINGOENCEPHALITIS HERPETIC 12 0.0268
49 PERIPHERAL VENOUS DISEASE 107 0.0262
50 RADICULOPATHY 69 0.0262
51 BODY MASS INDEX DECREASED 12 0.0259
52 METAL POISONING 15 0.0259
53 REFLEXES ABNORMAL 16 0.0247
54 RHEUMATIC FEVER 110 0.0247
55 DUST ALLERGY 24 0.0245
56 HUMAN HERPESVIRUS 6 INFECTION 46 0.0243
57 PROCTITIS 67 0.0239
58 PORPHYRIA ACUTE 34 0.0237
59 CHRONIC SINUSITIS 85 0.0226
60 DUODENAL ULCER PERFORATION 166 0.0223
61 PROTEUS INFECTION 16 0.0223
62 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 46 0.0222
63 C-REACTIVE PROTEIN ABNORMAL 137 0.0213
64 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 42 0.0206
65 BLINDNESS CORTICAL 10 0.0204
66 MATERNAL EXPOSURE TIMING UNSPECIFIED 74 0.0197
67 RHEUMATOID FACTOR POSITIVE 107 0.0185
68 PLEURITIC PAIN 51 0.0185
69 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 49 0.0184
70 DELAYED GRAFT FUNCTION 13 0.0183
71 CREPITATIONS 53 0.0178
72 TENOSYNOVITIS 48 0.0174
73 NASAL MUCOSAL DISORDER 10 0.0172
74 FOLLICULITIS 178 0.0170
75 RHEUMATOID NODULE 46 0.0167
76 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 107 0.0165
77 VULVOVAGINAL CANDIDIASIS 22 0.0163
78 EROSIVE DUODENITIS 13 0.0163
79 FORCED EXPIRATORY VOLUME DECREASED 46 0.0162
80 X-RAY ABNORMAL 29 0.0162
81 CONJUNCTIVITIS ALLERGIC 24 0.0162
82 COGWHEEL RIGIDITY 17 0.0162
83 CUSHINGOID 52 0.0162
84 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 114 0.0159
85 MUSCLE INJURY 131 0.0158
86 RESPIRATORY SYMPTOM 43 0.0151
87 HELICOBACTER INFECTION 155 0.0151
88 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 10 0.0150
89 DISLOCATION OF VERTEBRA 34 0.0149
90 RETINITIS 25 0.0145
91 HAND DEFORMITY 189 0.0144
92 SYNOVITIS 255 0.0141
93 ENTEROVIRUS INFECTION 12 0.0139
94 SUPERINFECTION 20 0.0133
95 BURSITIS 156 0.0128
96 ANTINUCLEAR ANTIBODY POSITIVE 41 0.0126
97 MACULAR DEGENERATION 146 0.0122
98 EXCESSIVE EYE BLINKING 18 0.0122
99 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 10 0.0122
100 FIBROMYALGIA 296 0.0122
101 JOINT RANGE OF MOTION DECREASED 161 0.0120
102 LIP DRY 109 0.0120
103 PEMPHIGUS 150 0.0120
104 ALLODYNIA 14 0.0120
105 REBOUND ACID HYPERSECRETION 36 0.0119
106 RETROPERITONEAL HAEMATOMA 26 0.0118
107 RESPIRATORY TRACT INFECTION VIRAL 27 0.0116
108 PALMAR ERYTHEMA 13 0.0113
109 CYSTITIS NONINFECTIVE 15 0.0112
110 HYPERPARATHYROIDISM SECONDARY 28 0.0112
111 NAIL INFECTION 16 0.0112
112 LIP ULCERATION 13 0.0111
113 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.0106
114 SWOLLEN TONGUE 331 0.0106
115 OSTEOPOROTIC FRACTURE 20 0.0104
116 CLOSTRIDIUM TEST POSITIVE 23 0.0104
117 NEUTROPENIC SEPSIS 74 0.0104
118 BONE EROSION 36 0.0102
119 ESCHERICHIA TEST POSITIVE 12 0.0100
120 BRONCHIAL OBSTRUCTION 14 0.0100
121 SYNOVIAL CYST 46 0.0100
122 BLADDER TRANSITIONAL CELL CARCINOMA 14 0.0098
123 MEGACOLON 15 0.0095
124 TENDERNESS 99 0.0095
125 NEUROLOGICAL SYMPTOM 54 0.0094
126 AUTOIMMUNE DISORDER 91 0.0093
127 IATROGENIC INJURY 12 0.0093
128 JOINT NOISE 18 0.0092
129 BACTERIAL TEST POSITIVE 20 0.0090
130 RECTAL ABSCESS 15 0.0089
131 TONSILLAR HYPERTROPHY 15 0.0089
132 FOAMING AT MOUTH 18 0.0089
133 PROCTALGIA 56 0.0087
134 NORMOCHROMIC NORMOCYTIC ANAEMIA 26 0.0086
135 BREAST CANCER STAGE III 56 0.0086
136 POTENTIATING DRUG INTERACTION 29 0.0086
137 HYPERACUSIS 32 0.0086
138 UROSEPSIS 78 0.0084
139 VAGINAL DISCHARGE 85 0.0084
140 PULMONARY ALVEOLAR HAEMORRHAGE 47 0.0084
141 CLOSTRIDIUM COLITIS 10 0.0082
142 INHIBITORY DRUG INTERACTION 13 0.0082
143 PERICARDITIS 138 0.0082
144 GLOSSODYNIA 182 0.0081
145 IRRITABLE BOWEL SYNDROME 174 0.0081
146 JOINT CREPITATION 16 0.0081
147 NEPHROGENIC ANAEMIA 37 0.0080
148 RENAL ARTERY STENOSIS 11 0.0080
149 BACTERIAL SEPSIS 26 0.0080
150 SYSTEMIC CANDIDA 20 0.0080
151 FUNCTIONAL GASTROINTESTINAL DISORDER 27 0.0078
152 ESCHERICHIA URINARY TRACT INFECTION 33 0.0078
153 JOINT EFFUSION 53 0.0077
154 TEMPERATURE REGULATION DISORDER 17 0.0076
155 PARAESTHESIA ORAL 110 0.0076
156 ORAL CANDIDIASIS 100 0.0076
157 APRAXIA 11 0.0074
158 EFFUSION 10 0.0073
159 SECONDARY ADRENOCORTICAL INSUFFICIENCY 11 0.0073
160 LOWER RESPIRATORY TRACT INFECTION 328 0.0072
161 SWELLING FACE 458 0.0070
162 SUBDURAL HAEMORRHAGE 19 0.0069
163 HYPOVOLAEMIC SHOCK 33 0.0069
164 THORACIC VERTEBRAL FRACTURE 20 0.0068
165 MOUTH SWELLING 39 0.0068
166 FOOD POISONING 36 0.0067
167 ANGIOEDEMA 296 0.0067
168 PULMONARY TOXICITY 47 0.0066
169 OPTIC NEUROPATHY 14 0.0066
170 LIVER FUNCTION TEST ABNORMAL 189 0.0065
171 MEAN CELL VOLUME DECREASED 10 0.0065
172 OBESITY 103 0.0065
173 WOUND INFECTION 70 0.0064
174 VASODILATATION 16 0.0063
175 SCIATICA 101 0.0063
176 PSEUDOMEMBRANOUS COLITIS 14 0.0063
177 HEPATOSPLENOMEGALY 16 0.0062
178 MOTION SICKNESS 12 0.0062
179 HYPERKALAEMIA 218 0.0062
180 IMPAIRED HEALING 203 0.0062
181 ATROPHY 12 0.0062
182 PULMONARY PAIN 18 0.0062
183 HAEMOGLOBIN INCREASED 28 0.0061
184 WOUND 171 0.0061
185 PSYCHOMOTOR SKILLS IMPAIRED 16 0.0061
186 ORAL PAIN 136 0.0061
187 ATELECTASIS 58 0.0060
188 FLANK PAIN 56 0.0060
189 SHOULDER ARTHROPLASTY 16 0.0059
190 ACCIDENTAL DEATH 11 0.0059
191 AORTIC ARTERIOSCLEROSIS 15 0.0058
192 PHOTOPHOBIA 109 0.0058
193 MICROCYTIC ANAEMIA 12 0.0058
194 PHYSICAL ASSAULT 12 0.0057
195 GASTROINTESTINAL PAIN 63 0.0057
196 MUSCLE CONTRACTIONS INVOLUNTARY 20 0.0057
197 LOWER LIMB FRACTURE 108 0.0056
198 CONTRAINDICATED PRODUCT ADMINISTERED 170 0.0056
199 NODULE 73 0.0056
200 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
201 PROSTATITIS 17 0.0056
202 DUODENITIS 17 0.0055
203 CONJUNCTIVITIS 102 0.0055
204 MUSCLE HAEMORRHAGE 22 0.0055
205 INCREASED BRONCHIAL SECRETION 14 0.0055
206 C-REACTIVE PROTEIN INCREASED 196 0.0054
207 ABNORMAL LOSS OF WEIGHT 36 0.0053
208 CLOSTRIDIUM DIFFICILE INFECTION 115 0.0053
209 DRUG INTOLERANCE 493 0.0051
210 SEDATION COMPLICATION 13 0.0051
211 OBSTRUCTIVE AIRWAYS DISORDER 56 0.0050
212 WALKING AID USER 33 0.0050
213 DRUG TOLERANCE DECREASED 14 0.0050
214 ARTERIOSCLEROSIS CORONARY ARTERY 33 0.0050
215 BLOOD CHOLESTEROL INCREASED 232 0.0050
216 HYPERCHOLESTEROLAEMIA 48 0.0050
217 MUCOSAL INFLAMMATION 130 0.0050
218 INFLAMMATION 256 0.0050
219 LIVER ABSCESS 16 0.0049
220 POOR PERIPHERAL CIRCULATION 21 0.0049
221 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
222 LYMPHOCYTE COUNT INCREASED 16 0.0049
223 LIVE BIRTH 41 0.0049
224 HYPONATRAEMIA 274 0.0049
225 WHEEZING 288 0.0049
226 POLYCYTHAEMIA 10 0.0048
227 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 16 0.0048
228 TYPE 2 DIABETES MELLITUS 163 0.0048
229 DYSPHONIA 282 0.0048
230 DEFORMITY 45 0.0048
231 ACUTE GRAFT VERSUS HOST DISEASE 22 0.0048
232 MYOSITIS 43 0.0048
233 GASTROINTESTINAL TOXICITY 23 0.0048
234 GRIP STRENGTH DECREASED 42 0.0048
235 HAEMORRHOIDS 93 0.0048
236 SYSTEMIC LUPUS ERYTHEMATOSUS 168 0.0047
237 EXOSTOSIS 43 0.0047
238 PRESCRIBED OVERDOSE 91 0.0047
239 CANCER PAIN 12 0.0047
240 OCULOGYRIC CRISIS 10 0.0047
241 LIP SWELLING 155 0.0046
242 PUSTULE 11 0.0046
243 WEIGHT ABNORMAL 11 0.0046
244 FULL BLOOD COUNT ABNORMAL 48 0.0045
245 PULMONARY FIBROSIS 87 0.0045
246 VOMITING PROJECTILE 13 0.0045
247 WHITE BLOOD CELL DISORDER 12 0.0045
248 ABDOMINAL TENDERNESS 22 0.0044
249 BODY TEMPERATURE INCREASED 89 0.0044
250 URINARY TRACT INFECTION BACTERIAL 11 0.0043
251 SKIN ATROPHY 25 0.0043
252 RECTAL HAEMORRHAGE 183 0.0043
253 PRURITUS GENITAL 10 0.0042
254 NAIL DISORDER 37 0.0042
255 TENDON PAIN 32 0.0042
256 VASCULITIS 49 0.0042
257 TENDONITIS 65 0.0042
258 LIVER INJURY 103 0.0042
259 LUNG DISORDER 205 0.0042
260 EJECTION FRACTION DECREASED 65 0.0042
261 INFUSION RELATED REACTION 277 0.0042
262 STARING 10 0.0041
263 NIGHT SWEATS 133 0.0041
264 END STAGE RENAL DISEASE 75 0.0041
265 FAECAL CALPROTECTIN INCREASED 13 0.0041
266 MUSCULOSKELETAL PAIN 214 0.0041
267 LUPUS-LIKE SYNDROME 37 0.0041
268 ARTERIOSCLEROSIS 38 0.0040
269 ACUTE KIDNEY INJURY 615 0.0040
270 INTERNATIONAL NORMALISED RATIO INCREASED 114 0.0040
271 ELECTRIC SHOCK SENSATION 11 0.0039
272 DYSAESTHESIA 12 0.0039
273 MEAN CELL VOLUME INCREASED 10 0.0039
274 CACHEXIA 20 0.0039
275 HYDRONEPHROSIS 29 0.0039
276 THERAPEUTIC PRODUCT EFFECT DECREASED 172 0.0038
277 APLASTIC ANAEMIA 20 0.0038
278 PERSONALITY DISORDER 10 0.0038
279 HALLUCINATIONS, MIXED 16 0.0038
280 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39 0.0038
281 HYPERVENTILATION 22 0.0038
282 GAIT INABILITY 126 0.0038
283 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 33 0.0037
284 LEUKOPENIA 185 0.0037
285 FREQUENT BOWEL MOVEMENTS 99 0.0037
286 COMMUNICATION DISORDER 14 0.0037
287 FEBRILE NEUTROPENIA 242 0.0036
288 RASH MACULO-PAPULAR 81 0.0036
289 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0036
290 PREGNANCY 72 0.0036
291 LIVER DISORDER 158 0.0036
292 CANDIDA INFECTION 60 0.0035
293 CYTOMEGALOVIRUS INFECTION 59 0.0035
294 THROMBOCYTOSIS 13 0.0035
295 CLOSTRIDIAL INFECTION 12 0.0035
296 FEBRILE BONE MARROW APLASIA 15 0.0035
297 STOMATITIS 214 0.0035
298 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
299 MUSCLE TWITCHING 81 0.0035
300 MOUTH ULCERATION 74 0.0035
301 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 248 0.0035
302 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
303 MYOPATHY 30 0.0035
304 ACTINIC KERATOSIS 9 0.0035
305 CHRONIC KIDNEY DISEASE 263 0.0035
306 ARTHROPATHY 191 0.0034
307 ERYTHEMA MULTIFORME 32 0.0034
308 JOINT SWELLING 414 0.0034
309 INFLAMMATORY MARKER INCREASED 17 0.0034
310 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
311 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 185 0.0034
312 TRANSPLANT REJECTION 27 0.0034
313 KIDNEY TRANSPLANT REJECTION 16 0.0033
314 ORTHOSTATIC HYPOTENSION 58 0.0033
315 MONOCYTE COUNT INCREASED 12 0.0033
316 BLISTER 185 0.0033
317 POLYDIPSIA 13 0.0033
318 URINARY TRACT INFECTION 560 0.0033
319 OEDEMA 178 0.0033
320 PSEUDOMONAS INFECTION 28 0.0033
321 SKIN ABRASION 15 0.0032
322 SWELLING 297 0.0032
323 OSTEOARTHRITIS 134 0.0032
324 ROAD TRAFFIC ACCIDENT 132 0.0032
325 PROCEDURAL PAIN 87 0.0031
326 MENINGITIS ASEPTIC 14 0.0031
327 DEAFNESS UNILATERAL 17 0.0031
328 DELIRIUM 107 0.0031
329 DECUBITUS ULCER 25 0.0031
330 PHARYNGITIS 38 0.0031
331 INFECTION 443 0.0031
332 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
333 ACCIDENT 36 0.0030
334 VENTRICULAR ARRHYTHMIA 11 0.0030
335 CONFUSIONAL STATE 484 0.0030
336 MEDICATION ERROR 166 0.0030
337 SQUAMOUS CELL CARCINOMA OF SKIN 18 0.0030
338 PERIPHERAL SWELLING 458 0.0030
339 HYPERSENSITIVITY 551 0.0030
340 DERMATITIS ALLERGIC 37 0.0029
341 CYTOKINE RELEASE SYNDROME 59 0.0029
342 HEPATIC CIRRHOSIS 55 0.0029
343 PSORIATIC ARTHROPATHY 118 0.0029
344 ULCER 46 0.0029
345 BLOOD CREATININE ABNORMAL 10 0.0029
346 CONGESTIVE CARDIOMYOPATHY 12 0.0029
347 STEVENS-JOHNSON SYNDROME 64 0.0029
348 ATAXIA 34 0.0029
349 RENAL FAILURE ACUTE 121 0.0028
350 FEELING JITTERY 54 0.0028
351 FOOT OPERATION 14 0.0028
352 CIRCULATORY COLLAPSE 48 0.0028
353 CONTUSION 271 0.0028
354 MUSCULOSKELETAL STIFFNESS 246 0.0028
355 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
356 DRY MOUTH 227 0.0028
357 THROMBOTIC MICROANGIOPATHY 27 0.0028
358 KLEBSIELLA INFECTION 14 0.0028
359 MUSCLE SPASTICITY 34 0.0028
360 RALES 16 0.0028
361 COLITIS MICROSCOPIC 13 0.0027
362 DIVERTICULUM INTESTINAL 12 0.0027
363 OLIGURIA 17 0.0027
364 HYPOPHAGIA 70 0.0027
365 ENDOCARDITIS 14 0.0027
366 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
367 NEURALGIA 66 0.0027
368 MOBILITY DECREASED 194 0.0027
369 BLEPHAROSPASM 17 0.0027
370 DRUG INTERACTION 428 0.0027
371 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
372 MUSCLE RIGIDITY 32 0.0027
373 JOINT STIFFNESS 70 0.0027
374 IRON DEFICIENCY 12 0.0027
375 SNORING 10 0.0026
376 SEPTIC SHOCK 115 0.0026
377 RENAL PAIN 28 0.0026
378 UNRESPONSIVE TO STIMULI 68 0.0026
379 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
380 EYE MOVEMENT DISORDER 18 0.0026
381 FORMICATION 18 0.0026
382 SLEEP DISORDER 181 0.0026
383 HEPATOTOXICITY 57 0.0026
384 ABNORMAL SENSATION IN EYE 11 0.0026
385 ARTHRITIS 201 0.0026
386 SUBARACHNOID HAEMORRHAGE 26 0.0026
387 HIP ARTHROPLASTY 39 0.0025
388 PHOTOSENSITIVITY REACTION 42 0.0025
389 NEUTROPHIL COUNT INCREASED 26 0.0025
390 RESPIRATORY TRACT INFECTION 66 0.0025
391 IMPAIRED WORK ABILITY 54 0.0025
392 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
393 ILL-DEFINED DISORDER 153 0.0025
394 HEPATITIS 64 0.0025
395 ENTERITIS 16 0.0025
396 CYTOMEGALOVIRUS INFECTION REACTIVATION 11 0.0025
397 HERPES ZOSTER 143 0.0025
398 RED BLOOD CELL COUNT DECREASED 71 0.0025
399 SKIN ULCER 64 0.0025
400 HYPOGAMMAGLOBULINAEMIA 16 0.0024
401 DEFAECATION URGENCY 17 0.0024
402 VASCULAR DEVICE INFECTION 11 0.0024
403 MYELODYSPLASTIC SYNDROME 35 0.0024
404 SOCIAL AVOIDANT BEHAVIOUR 14 0.0024
405 EAR PAIN 47 0.0024
406 HAEMOPTYSIS 67 0.0024
407 COLITIS 90 0.0024
408 RESPIRATORY RATE INCREASED 21 0.0024
409 RHINITIS 19 0.0024
410 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 40 0.0024
411 PANCYTOPENIA 131 0.0023
412 DISCOMFORT 143 0.0023
413 COLITIS ULCERATIVE 104 0.0023
414 HEPATITIS CHOLESTATIC 14 0.0023
415 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
416 BLOOD MAGNESIUM DECREASED 20 0.0023
417 PRESYNCOPE 56 0.0023
418 REFUSAL OF TREATMENT BY PATIENT 15 0.0023
419 URINE OUTPUT DECREASED 20 0.0023
420 HALLUCINATION, VISUAL 48 0.0023
421 CYSTITIS 72 0.0023
422 BREAST PAIN 24 0.0022
423 NEPHROPATHY 21 0.0022
424 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
425 SKIN WARM 13 0.0022
426 BLOOD SODIUM DECREASED 42 0.0022
427 URINARY INCONTINENCE 66 0.0022
428 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63 0.0022
429 INJURY 156 0.0022
430 HEPATIC ENZYME INCREASED 151 0.0022
431 BLOOD UREA INCREASED 37 0.0022
432 CYTOPENIA 27 0.0022
433 DRUG-INDUCED LIVER INJURY 69 0.0022
434 PYELONEPHRITIS 19 0.0022
435 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
436 UPPER RESPIRATORY TRACT INFECTION 101 0.0022
437 ABDOMINAL PAIN 508 0.0022
438 DEMENTIA 61 0.0022
439 ODYNOPHAGIA 13 0.0022
440 RASH PRURITIC 118 0.0022
441 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
442 GRAND MAL CONVULSION 20 0.0022
443 GASTROINTESTINAL DISORDER 194 0.0022
444 HYPOPHOSPHATAEMIA 16 0.0022
445 PYREXIA 749 0.0022
446 BLOOD POTASSIUM INCREASED 35 0.0022
447 VARICOSE VEIN 11 0.0021
448 SENSORY DISTURBANCE 34 0.0021
449 BONE MARROW FAILURE 43 0.0021
450 DRUG LEVEL INCREASED 35 0.0021
451 VIRAL UPPER RESPIRATORY TRACT INFECTION 10 0.0021
452 SALIVARY HYPERSECRETION 21 0.0021
453 URINARY RETENTION 70 0.0021
454 TERMINAL STATE 14 0.0021
455 JOINT DISLOCATION 22 0.0021
456 JAUNDICE 56 0.0021
457 PANIC REACTION 15 0.0021
458 GENERAL PHYSICAL HEALTH DETERIORATION 240 0.0021
459 HICCUPS 17 0.0021
460 DISORIENTATION 82 0.0021
461 RASH VESICULAR 10 0.0021
462 EAR INFECTION 55 0.0021
463 MATERNAL EXPOSURE DURING PREGNANCY 184 0.0021
464 RHEUMATOID ARTHRITIS 234 0.0021
465 PHOTOPSIA 13 0.0021
466 MUSCLE ATROPHY 26 0.0021
467 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
468 RASH GENERALISED 53 0.0020
469 SINUS TACHYCARDIA 29 0.0020
470 NORMAL NEWBORN 11 0.0020
471 BLOOD CREATININE INCREASED 132 0.0020
472 MUCOUS STOOLS 10 0.0020
473 WEIGHT FLUCTUATION 21 0.0020
474 PRESCRIBED UNDERDOSE 40 0.0020
475 FLUID INTAKE REDUCED 10 0.0020
476 MUSCULAR WEAKNESS 226 0.0020
477 FOOT DEFORMITY 22 0.0020
478 MALAISE 870 0.0020
479 DRY EYE 99 0.0020
480 SINUSITIS 203 0.0020
481 PATHOLOGICAL FRACTURE 10 0.0020
482 GASTROOESOPHAGEAL REFLUX DISEASE 158 0.0020
483 RETINAL DETACHMENT 18 0.0020
484 THERAPY NON-RESPONDER 88 0.0020
485 FEMORAL NECK FRACTURE 10 0.0019
486 IRON DEFICIENCY ANAEMIA 18 0.0019
487 EYE PAIN 110 0.0019
488 KNEE ARTHROPLASTY 41 0.0019
489 LETHARGY 112 0.0019
490 VITREOUS FLOATERS 19 0.0019
491 BLOOD POTASSIUM DECREASED 58 0.0019
492 BREAST CANCER STAGE II 16 0.0019
493 BONE DENSITY DECREASED 60 0.0019
494 MULTIPLE ALLERGIES 15 0.0019
495 EOSINOPHILIA 33 0.0019
496 HYPOTHYROIDISM 60 0.0019
497 RESPIRATORY DISORDER 56 0.0019
498 QUALITY OF LIFE DECREASED 25 0.0019
499 TREATMENT FAILURE 154 0.0019
500 GINGIVITIS 10 0.0019
501 DYSPEPSIA 182 0.0018
502 NIGHTMARE 64 0.0018
503 CELLULITIS 93 0.0018
504 LYMPHOPENIA 26 0.0018
505 PETECHIAE 19 0.0018
506 RENAL FAILURE CHRONIC 14 0.0018
507 ADVERSE REACTION 24 0.0018
508 INCONTINENCE 19 0.0018
509 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
510 INTENTIONAL PRODUCT USE ISSUE 156 0.0018
511 ABDOMINAL PAIN LOWER 45 0.0018
512 BLOOD CALCIUM DECREASED 20 0.0018
513 HYPOKALAEMIA 82 0.0018
514 DRUG TOXICITY 24 0.0018
515 PATHOGEN RESISTANCE 16 0.0018
516 URTICARIA 294 0.0018
517 DIZZINESS POSTURAL 17 0.0018
518 HAEMOGLOBIN DECREASED 180 0.0018
519 PARAESTHESIA 275 0.0017
520 RENAL FAILURE 232 0.0017
521 CARDIAC MURMUR 15 0.0017
522 THROMBOCYTOPENIA 193 0.0017
523 ANAEMIA 329 0.0017
524 HYPOMAGNESAEMIA 24 0.0017
525 INTERSTITIAL LUNG DISEASE 83 0.0017
526 NEUROTOXICITY 30 0.0017
527 HYPERAESTHESIA 14 0.0017
528 DUODENAL ULCER 12 0.0017
529 URINE ODOUR ABNORMAL 10 0.0017
530 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 14 0.0017
531 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
532 DECREASED INTEREST 10 0.0017
533 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 29 0.0017
534 MUSCULOSKELETAL DISORDER 32 0.0017
535 HYPOTHERMIA 17 0.0017
536 ANAL INCONTINENCE 15 0.0017
537 OCULAR HYPERAEMIA 79 0.0017
538 HAEMATOCHEZIA 91 0.0016
539 OESOPHAGITIS 18 0.0016
540 HYPOXIA 58 0.0016
541 EATING DISORDER 35 0.0016
542 POST-TRAUMATIC STRESS DISORDER 11 0.0016
543 PNEUMONIA ASPIRATION 41 0.0016
544 RENAL IMPAIRMENT 137 0.0016
545 THROAT TIGHTNESS 44 0.0016
546 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78 0.0016
547 SEPSIS 181 0.0016
548 PIGMENTATION DISORDER 10 0.0016
549 PRURITUS GENERALISED 35 0.0016
550 TINNITUS 74 0.0016
551 ASTHMA 182 0.0016
552 RASH MACULAR 56 0.0016
553 BACTERAEMIA 19 0.0016
554 NEUTROPENIA 217 0.0016
555 VOMITING 746 0.0016
556 BRAIN OEDEMA 20 0.0016
557 PULMONARY EMBOLISM 150 0.0016
558 EXTRASYSTOLES 11 0.0016
559 ABDOMINAL PAIN UPPER 324 0.0016
560 ACIDOSIS 12 0.0016
561 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
562 HYPOAESTHESIA 234 0.0016
563 PALPITATIONS 183 0.0016
564 PAPULE 11 0.0016
565 MUSCULOSKELETAL CHEST PAIN 24 0.0015
566 ELECTROLYTE IMBALANCE 18 0.0015
567 PLEURAL EFFUSION 94 0.0015
568 HIATUS HERNIA 20 0.0015
569 FEELING COLD 43 0.0015
570 RESTLESS LEGS SYNDROME 28 0.0015
571 HYPERCALCAEMIA 19 0.0015
572 ACUTE HEPATIC FAILURE 21 0.0015
573 CONSTIPATION 335 0.0015
574 DISEASE RECURRENCE 73 0.0015
575 CHEST DISCOMFORT 157 0.0015
576 DEAFNESS 40 0.0015
577 TORSADE DE POINTES 12 0.0015
578 PRODUCTIVE COUGH 73 0.0015
579 NEUTROPHIL COUNT DECREASED 62 0.0015
580 HYPERTENSION 322 0.0015
581 HAEMATURIA 52 0.0015
582 OSTEOPENIA 23 0.0015
583 NEPHROPATHY TOXIC 17 0.0015
584 RENAL CYST 12 0.0015
585 HALLUCINATION 113 0.0015
586 PHARYNGEAL OEDEMA 23 0.0015
587 DECREASED APPETITE 347 0.0015
588 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
589 HEPATIC CYTOLYSIS 19 0.0015
590 STAPHYLOCOCCAL INFECTION 49 0.0015
591 NEUROPATHY PERIPHERAL 141 0.0015
592 SPINAL OSTEOARTHRITIS 13 0.0015
593 TUMOUR LYSIS SYNDROME 13 0.0015
594 BACK PAIN 343 0.0015
595 DYSKINESIA 60 0.0015
596 SKIN LACERATION 16 0.0015
597 THROMBOSIS 118 0.0015
598 POLLAKIURIA 61 0.0015
599 ESCHERICHIA INFECTION 12 0.0015
600 PLATELET COUNT INCREASED 19 0.0015
601 PERIPHERAL COLDNESS 20 0.0015
602 ACUTE RESPIRATORY FAILURE 28 0.0015
603 RASH 633 0.0015
604 SPINAL COMPRESSION FRACTURE 12 0.0014
605 HEADACHE 910 0.0014
606 RESPIRATORY DISTRESS 40 0.0014
607 BALANCE DISORDER 125 0.0014
608 RASH ERYTHEMATOUS 69 0.0014
609 GASTROENTERITIS VIRAL 26 0.0014
610 ABDOMINAL DISCOMFORT 240 0.0014
611 CHEST PAIN 265 0.0014
612 CONDITION AGGRAVATED 435 0.0014
613 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
614 MYOCLONUS 17 0.0014
615 TREMOR 235 0.0014
616 HYPOALBUMINAEMIA 11 0.0014
617 BLADDER DISORDER 14 0.0014
618 DYSARTHRIA 53 0.0014
619 MICTURITION URGENCY 16 0.0014
620 NECK PAIN 78 0.0014
621 BLOOD CREATINE PHOSPHOKINASE INCREASED 40 0.0014
622 TRICUSPID VALVE INCOMPETENCE 11 0.0014
623 INSOMNIA 368 0.0014
624 HAEMATEMESIS 35 0.0014
625 FEEDING DISORDER 28 0.0014
626 KIDNEY INFECTION 27 0.0014
627 ARTHRALGIA 571 0.0014
628 FEELING HOT 84 0.0014
629 OEDEMA PERIPHERAL 167 0.0014
630 HAEMATOTOXICITY 13 0.0014
631 MOUTH HAEMORRHAGE 10 0.0014
632 DYSURIA 50 0.0014
633 MUSCLE DISORDER 11 0.0014
634 LYMPHOCYTE COUNT DECREASED 24 0.0014
635 DIARRHOEA 876 0.0014
636 DYSPNOEA 763 0.0013
637 EPILEPSY 41 0.0013
638 CHROMATURIA 30 0.0013
639 OROPHARYNGEAL DISCOMFORT 12 0.0013
640 COGNITIVE DISORDER 62 0.0013
641 RENAL TUBULAR NECROSIS 13 0.0013
642 PNEUMONIA 429 0.0013
643 DECREASED IMMUNE RESPONSIVENESS 13 0.0013
644 HALLUCINATION, AUDITORY 21 0.0013
645 SCHIZOPHRENIA 16 0.0013
646 CHILLS 154 0.0013
647 CONVULSION 75 0.0013
648 JOINT INJURY 28 0.0013
649 PNEUMONIA BACTERIAL 12 0.0013
650 DYSPHAGIA 123 0.0013
651 APHASIA 39 0.0013
652 PULMONARY CONGESTION 17 0.0013
653 APHTHOUS ULCER 10 0.0013
654 DYSTONIA 25 0.0013
655 WEIGHT DECREASED 359 0.0013
656 CARDIOMYOPATHY 19 0.0013
657 OROPHARYNGEAL PAIN 119 0.0013
658 BRADYCARDIA 68 0.0013
659 LOCALISED INFECTION 31 0.0013
660 RENAL INJURY 38 0.0013
661 SKIN REACTION 18 0.0013
662 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
663 MULTI-ORGAN FAILURE 22 0.0013
664 RHABDOMYOLYSIS 53 0.0013
665 ANXIETY 361 0.0013
666 DIZZINESS 632 0.0013
667 PRODUCT USE IN UNAPPROVED INDICATION 314 0.0013
668 ADVERSE DRUG REACTION 113 0.0013
669 VENTRICULAR EXTRASYSTOLES 13 0.0013
670 METABOLIC ACIDOSIS 40 0.0012
671 CHOLELITHIASIS 41 0.0012
672 FULL BLOOD COUNT DECREASED 25 0.0012
673 AGRANULOCYTOSIS 23 0.0012
674 NAUSEA 977 0.0012
675 GASTROENTERITIS 18 0.0012
676 HYPOTENSION 247 0.0012
677 PARKINSONISM 12 0.0012
678 DEPRESSED MOOD 65 0.0012
679 AGITATION 90 0.0012
680 LUNG INFECTION 19 0.0012
681 POLYURIA 10 0.0012
682 DEHYDRATION 162 0.0012
683 PALLOR 33 0.0012
684 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
685 RASH PAPULAR 27 0.0012
686 MUSCLE SPASMS 221 0.0012
687 SPEECH DISORDER 63 0.0012
688 SECRETION DISCHARGE 15 0.0012
689 PRURITUS 460 0.0012
690 MYALGIA 203 0.0012
691 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
692 COVID-19 PNEUMONIA 14 0.0012
693 PANIC ATTACK 43 0.0012
694 TACHYPNOEA 16 0.0012
695 THIRST 21 0.0012
696 TACHYCARDIA 104 0.0012
697 HYPERTENSIVE CRISIS 13 0.0012
698 DRUG RESISTANCE 30 0.0012
699 OSTEOPOROSIS 48 0.0012
700 HYPOCALCAEMIA 22 0.0012
701 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
702 LEUKOCYTOSIS 21 0.0012
703 PARANOIA 20 0.0012
704 INTESTINAL PERFORATION 13 0.0012
705 PROTEINURIA 22 0.0012
706 DEEP VEIN THROMBOSIS 75 0.0012
707 PLATELET COUNT DECREASED 123 0.0012
708 SEROTONIN SYNDROME 22 0.0011
709 CYANOSIS 18 0.0011
710 PNEUMOTHORAX 18 0.0011
711 TASTE DISORDER 23 0.0011
712 PURPURA 10 0.0011
713 HEAD DISCOMFORT 20 0.0011
714 DRUG ERUPTION 20 0.0011
715 EXTRAPYRAMIDAL DISORDER 28 0.0011
716 LACRIMATION INCREASED 34 0.0011
717 BLOOD PRESSURE FLUCTUATION 27 0.0011
718 ASTHENIA 422 0.0011
719 DIVERTICULITIS 31 0.0011
720 VERTIGO 68 0.0011
721 OFF LABEL USE 959 0.0011
722 PAIN IN JAW 31 0.0011
723 CHOLESTASIS 21 0.0011
724 CARDIAC ARREST 90 0.0011
725 NASOPHARYNGITIS 200 0.0011
726 ERYTHEMA 222 0.0011
727 COLD SWEAT 19 0.0011
728 PERSONALITY CHANGE 10 0.0011
729 BACTERIAL INFECTION 20 0.0011
730 POOR QUALITY SLEEP 23 0.0011
731 ANAPHYLACTIC REACTION 59 0.0011
732 IMMUNE SYSTEM DISORDER 14 0.0011
733 HYPOGLYCAEMIA 51 0.0011
734 MUSCLE TIGHTNESS 17 0.0010
735 PAIN IN EXTREMITY 308 0.0010
736 ALOPECIA 205 0.0010
737 FEAR 28 0.0010
738 PAIN OF SKIN 28 0.0010
739 SYNCOPE 104 0.0010
740 DYSPNOEA EXERTIONAL 39 0.0010
741 SEIZURE 119 0.0010
742 EXPOSURE DURING PREGNANCY 64 0.0010
743 ANHEDONIA 27 0.0010
744 PHARYNGEAL SWELLING 10 0.0010
745 COELIAC DISEASE 10 0.0010
746 MIDDLE INSOMNIA 19 0.0010
747 LABORATORY TEST ABNORMAL 30 0.0010
748 AMNESIA 66 0.0010
749 PAIN 623 0.0010
750 EYE IRRITATION 58 0.0010
751 BONE PAIN 59 0.0010
752 PULMONARY MASS 15 0.0010
753 HYPERLIPIDAEMIA 12 0.0010
754 COORDINATION ABNORMAL 14 0.0010
755 HEMIPARESIS 17 0.0010
756 OVARIAN CYST 10 0.0010
757 ILLNESS 103 0.0010
758 GASTRIC ULCER 19 0.0010
759 PERICARDIAL EFFUSION 23 0.0010
760 VIRAL INFECTION 33 0.0010
761 GASTRITIS 26 0.0010
762 MALNUTRITION 11 0.0010
763 SNEEZING 22 0.0010
764 ENCEPHALOPATHY 24 0.0010
765 TENDON RUPTURE 12 0.0010
766 DISEASE PROGRESSION 115 0.0010
767 WEIGHT INCREASED 217 0.0010
768 FAECES DISCOLOURED 21 0.0010
769 PRODUCT PRESCRIBING ERROR 23 0.0010
770 UVEITIS 13 0.0010
771 GASTROINTESTINAL HAEMORRHAGE 80 0.0010
772 FEELING ABNORMAL 229 0.0010
773 MELAENA 21 0.0010
774 PLASMA CELL MYELOMA 37 0.0009
775 ATRIAL FIBRILLATION 92 0.0009
776 OXYGEN SATURATION DECREASED 53 0.0009
777 BURNING SENSATION 66 0.0009
778 LIVER FUNCTION TEST INCREASED 20 0.0009
779 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
780 THINKING ABNORMAL 17 0.0009
781 MIGRAINE 86 0.0009
782 SKIN INFECTION 10 0.0009
783 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
784 SOMNOLENCE 179 0.0009
785 HEART RATE INCREASED 88 0.0009
786 HAEMATOMA 23 0.0009
787 VISUAL IMPAIRMENT 110 0.0009
788 MITRAL VALVE INCOMPETENCE 10 0.0009
789 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
790 FATIGUE 683 0.0009
791 VISION BLURRED 120 0.0009
792 VISUAL ACUITY REDUCED 29 0.0009
793 MYOCARDITIS 10 0.0009
794 CARDIAC FAILURE 70 0.0009
795 MENTAL STATUS CHANGES 24 0.0009
796 EYELID OEDEMA 10 0.0009
797 HEPATIC STEATOSIS 16 0.0009
798 ECONOMIC PROBLEM 13 0.0009
799 FALL 285 0.0009
800 SPLENOMEGALY 10 0.0009
801 RESPIRATORY FAILURE 62 0.0008
802 COUGH 238 0.0008
803 DIPLOPIA 22 0.0008
804 RESTLESSNESS 31 0.0008
805 FLUID RETENTION 43 0.0008
806 GAIT DISTURBANCE 161 0.0008
807 PRODUCT USE ISSUE 158 0.0008
808 CHOLECYSTITIS 10 0.0008
809 SKIN LESION 23 0.0008
810 HYPERSOMNIA 24 0.0008
811 LACTIC ACIDOSIS 27 0.0008
812 BASAL CELL CARCINOMA 13 0.0008
813 HEPATIC FAILURE 25 0.0008
814 MENTAL IMPAIRMENT 20 0.0008
815 DYSSTASIA 24 0.0008
816 AGGRESSION 41 0.0008
817 PANCREATITIS 43 0.0008
818 NEOPLASM MALIGNANT 54 0.0008
819 DISABILITY 16 0.0008
820 HYPERHIDROSIS 104 0.0008
821 NEOPLASM PROGRESSION 28 0.0008
822 BLOOD PRESSURE ABNORMAL 16 0.0008
823 HAEMORRHAGE INTRACRANIAL 12 0.0008
824 ARRHYTHMIA 38 0.0008
825 BACK DISORDER 13 0.0008
826 RESPIRATORY ARREST 22 0.0008
827 METASTASES TO LIVER 14 0.0008
828 ACCIDENTAL OVERDOSE 29 0.0008
829 EPISTAXIS 59 0.0008
830 VENTRICULAR TACHYCARDIA 13 0.0008
831 DRUG DISPENSING ERROR 12 0.0008
832 PRODUCT PRESCRIBING ISSUE 17 0.0008
833 MYELOSUPPRESSION 28 0.0008
834 FACE OEDEMA 13 0.0008
835 ACUTE MYELOID LEUKAEMIA 12 0.0008
836 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
837 COVID-19 133 0.0008
838 SARS-COV-2 TEST POSITIVE 10 0.0008
839 MEMORY IMPAIRMENT 104 0.0008
840 ABDOMINAL DISTENSION 78 0.0007
841 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
842 GINGIVAL BLEEDING 10 0.0007
843 EYE SWELLING 27 0.0007
844 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
845 ORAL DISCOMFORT 10 0.0007
846 OSTEOMYELITIS 13 0.0007
847 PULMONARY OEDEMA 32 0.0007
848 TREATMENT NONCOMPLIANCE 39 0.0007
849 MENTAL DISORDER 31 0.0007
850 DEPRESSION 162 0.0007
851 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
852 HEART RATE IRREGULAR 16 0.0007
853 BLOOD PRESSURE DECREASED 47 0.0007
854 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
855 PNEUMONITIS 19 0.0007
856 HIP FRACTURE 22 0.0007
857 DRUG PRESCRIBING ERROR 13 0.0007
858 IMMUNODEFICIENCY 10 0.0007
859 DIABETES MELLITUS 51 0.0007
860 LIMB INJURY 18 0.0007
861 TOXICITY TO VARIOUS AGENTS 110 0.0007
862 COMA 31 0.0007
863 DEVICE RELATED INFECTION 10 0.0006
864 DISTURBANCE IN ATTENTION 35 0.0006
865 THERAPY PARTIAL RESPONDER 10 0.0006
866 INTESTINAL OBSTRUCTION 24 0.0006
867 LOSS OF CONSCIOUSNESS 81 0.0006
868 ECZEMA 33 0.0006
869 FLUSHING 64 0.0006
870 BLOOD BILIRUBIN INCREASED 17 0.0006
871 ABORTION SPONTANEOUS 25 0.0006
872 BRONCHITIS 46 0.0006
873 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
874 ISCHAEMIC STROKE 11 0.0006
875 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
876 LUNG NEOPLASM MALIGNANT 25 0.0006
877 DRUG INEFFECTIVE 801 0.0006
878 ADVERSE EVENT 56 0.0006
879 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
880 SKIN DISORDER 20 0.0006
881 LYMPHADENOPATHY 21 0.0006
882 NEPHROLITHIASIS 27 0.0006
883 CEREBRAL HAEMORRHAGE 21 0.0006
884 RIB FRACTURE 12 0.0006
885 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
886 HYPOACUSIS 25 0.0006
887 FOOT FRACTURE 11 0.0006
888 PERITONITIS 12 0.0006
889 HYPERGLYCAEMIA 21 0.0006
890 PSYCHOTIC DISORDER 17 0.0006
891 CARDIO-RESPIRATORY ARREST 24 0.0006
892 RHINORRHOEA 37 0.0006
893 SKIN BURNING SENSATION 41 0.0006
894 FUNGAL INFECTION 19 0.0006
895 TARDIVE DYSKINESIA 16 0.0006
896 PREMATURE BABY 17 0.0006
897 GOUT 10 0.0006
898 SINUS DISORDER 11 0.0006
899 DRUG EFFECT INCOMPLETE 20 0.0006
900 INTENTIONAL PRODUCT MISUSE 48 0.0005
901 OSTEONECROSIS 18 0.0005
902 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
903 NERVOUS SYSTEM DISORDER 17 0.0005
904 CATARACT 32 0.0005
905 IRRITABILITY 32 0.0005
906 PULMONARY HYPERTENSION 11 0.0005
907 CARDIAC FAILURE CONGESTIVE 42 0.0005
908 RETCHING 11 0.0005
909 RENAL DISORDER 24 0.0005
910 HEART RATE DECREASED 18 0.0005
911 SKIN FISSURES 10 0.0005
912 SKIN EXFOLIATION 43 0.0005
913 THERAPY CESSATION 26 0.0005
914 HAEMATOCRIT DECREASED 10 0.0005
915 SPINAL FRACTURE 10 0.0005
916 MOOD ALTERED 13 0.0005
917 ACUTE MYOCARDIAL INFARCTION 14 0.0005
918 ABNORMAL DREAMS 13 0.0005
919 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
920 BLOOD PRESSURE INCREASED 71 0.0005
921 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
922 NASAL CONGESTION 27 0.0005
923 SEDATION 12 0.0005
924 HEPATIC FUNCTION ABNORMAL 17 0.0005
925 LIMB DISCOMFORT 14 0.0005
926 ASCITES 13 0.0004
927 CRYING 16 0.0004
928 VAGINAL HAEMORRHAGE 19 0.0004
929 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
930 CEREBROVASCULAR ACCIDENT 71 0.0004
931 HEAD INJURY 13 0.0004
932 FLATULENCE 23 0.0004
933 WITHDRAWAL SYNDROME 17 0.0004
934 OSTEONECROSIS OF JAW 10 0.0004
935 SKIN DISCOLOURATION 18 0.0004
936 UNDERDOSE 28 0.0004
937 GASTRIC DISORDER 13 0.0004
938 HOSPITALISATION 58 0.0004
939 SUICIDAL IDEATION 34 0.0004
940 INFLUENZA 41 0.0004
941 ABASIA 9 0.0004
942 MULTIPLE SCLEROSIS 17 0.0004
943 INFLUENZA LIKE ILLNESS 29 0.0004
944 DYSGEUSIA 26 0.0003
945 MOOD SWINGS 11 0.0003
946 HAEMORRHAGE 36 0.0003
947 OVERDOSE 74 0.0003
948 MOVEMENT DISORDER 11 0.0003
949 EYE DISORDER 11 0.0003
950 CARDIAC DISORDER 31 0.0003
951 CORONARY ARTERY DISEASE 10 0.0003
952 NERVOUSNESS 17 0.0003
953 EMOTIONAL DISORDER 10 0.0003
954 SURGERY 19 0.0003
955 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
956 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
957 MYOCARDIAL INFARCTION 53 0.0003
958 ABNORMAL BEHAVIOUR 12 0.0003
959 ANGER 10 0.0003
960 BLINDNESS 12 0.0003
961 DEATH 253 0.0003
962 THROAT IRRITATION 13 0.0003
963 DRUG ABUSE 23 0.0003
964 PRODUCT DOSE OMISSION ISSUE 80 0.0003
965 EXTRA DOSE ADMINISTERED 11 0.0003
966 DRY SKIN 36 0.0003
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
968 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 48 0.0003
969 HOT FLUSH 20 0.0003
970 EMOTIONAL DISTRESS 32 0.0003
971 COMPLETED SUICIDE 22 0.0003
972 THERAPEUTIC RESPONSE DECREASED 16 0.0003
973 INCORRECT DOSE ADMINISTERED 58 0.0003
974 UNEVALUABLE EVENT 19 0.0003
975 BLOOD GLUCOSE DECREASED 12 0.0002
976 DRUG EFFECT DECREASED 13 0.0002
977 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
978 PRODUCT DOSE OMISSION 14 0.0002
979 INJECTION SITE HAEMORRHAGE 17 0.0002
980 BLOOD GLUCOSE INCREASED 39 0.0002
981 DRUG WITHDRAWAL SYNDROME 18 0.0002
982 PSORIASIS 25 0.0002
983 DRUG DOSE OMISSION 26 0.0002
984 INJECTION SITE BRUISING 12 0.0002
985 ACNE 11 0.0001
986 INJECTION SITE ERYTHEMA 14 0.0001
987 PRODUCT QUALITY ISSUE 15 0.0001
988 NO ADVERSE EVENT 20 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
990 INJECTION SITE PAIN 16 0.0001